Specialties
Sean Ronnekleiv-Kelly, MD, FACS
Associate Professor
- Endowed Professor, Ronald E. and Patricia A. Kissinger Surgical Oncology Research Professorship
- Division of Surgical Oncology
ronnekleiv-kelly@surgery.wisc.edu
- Administrative Assistant: (608) 262-2025
600 Highland Avenue
Clinical Science Center
Madison WI 53792-7375
Education
- MD, University of Colorado School of Medicine
- General Surgery Residency, University of Wisconsin School of Medicine and Public Health
- Complex General Surgical Oncology Fellowship, Johns Hopkins Hospital
Clinical Specialties
Certified by the American Board of Surgery in General Surgery and specializes in malignant disease of the pancreas, liver, gallbladder and biliary tree, stomach and small intestine, neuroendocrine tumors and retroperitoneal sarcoma.
Research Interests
Principal research interest is pancreatic cancer. My lab focuses on formation and progression of pancreatic cancer as well as understanding communication within the tumor microenvironment.
Dr. Sean Ronnekleiv-Kelly was awarded a two-year, $276,000 grant from the Fibrolamellar Cancer Foundation. Read more here.
Recent Publications
Neoadjuvant SBRT plus Elective Nodal Irradiation with Concurrent Capecitabine for Patients with Resectable Pancreatic Cancer: Survival Analysis of a Prospective Phase 1 Trial.
Basree MM, Witt JS, Uboha NV, Lubner M, Minter R, Weber S, Ronnekleiv-Kelly S, Abbott D, Kratz J, Patel M, Zafar SN, LoConte N, Lubner SJ, Deming D, Ritter MA, Mohindra P, Bassetti MF
Pract Radiat Oncol 2025 Feb 07;
[PubMed ID: 39924052]Single-cell multi-omic analysis of fibrolamellar carcinoma reveals rewired cell-to-cell communication patterns and unique vulnerabilities.
Farghli AR, Chan M, Sherman MS, Dickerson LK, Shui B, Nukaya M, Stephanou A, Ma RK, Pepe-Mooney BJ, Smith CJ, Long D, Munn PR, McNairn A, Grenier JK, Karski M, Ronnekleiv-Kelly SM, Pillarisetty VG, Goessling W, Gujral TS, Vakili K, Sethupathy P
bioRxiv 2024 Dec 12;
[PubMed ID: 39713360]Understanding futility in pancreaticoduodenectomy: Insights from a national cohort.
Marcinak CT, Ahmed KS, LoConte NK, Praska CE, Varley PR, Weber SM, Abbott DE, Ronnekleiv-Kelly SM, Kratz JD, Lubner SJ, Minter RM, Zafar SN
J Surg Oncol 2024 Sep; 130(3): 462-475
[PubMed ID: 39082628]Circadian disruption, clock genes, and metabolic health.
Schrader LA, Ronnekleiv-Kelly SM, Hogenesch JB, Bradfield CA, Malecki KM
J Clin Invest 2024 Jul 15; 134(14)
[PubMed ID: 39007272]Diverse mechanisms by which chemical pollutant exposure alters gut microbiota metabolism and inflammation.
Teffera M, Veith AC, Ronnekleiv-Kelly S, Bradfield CA, Nikodemova M, Tussing-Humphreys L, Malecki K
Environ Int 2024 Aug; 190: 108805
[PubMed ID: 38901183]